Financial Management Professionals’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.2K | Buy |
790
+9
| +1% | +$629 | 0.01% | 243 |
|
|
2025
Q1 | $57.4K | Buy |
781
+200
| +34% | +$14.7K | 0.01% | 242 |
|
|
2024
Q4 | $38.1K | Sell |
581
-95
| -14% | -$6.22K | ﹤0.01% | 307 |
|
|
2024
Q3 | $53K | Buy |
676
+87
| +15% | +$6.82K | 0.01% | 264 |
|
|
2024
Q2 | $46K | Buy |
589
+25
| +4% | +$1.95K | 0.01% | 267 |
|
|
2024
Q1 | $38K | Buy |
564
+33
| +6% | +$2.22K | 0.01% | 323 |
|
|
2023
Q4 | $36K | Buy |
531
+23
| +5% | +$1.56K | 0.01% | 300 |
|
|
2023
Q3 | $34K | Sell |
508
-8
| -2% | -$535 | 0.01% | 287 |
|
|
2023
Q2 | $37K | Sell |
516
-619
| -55% | -$44.4K | 0.01% | 294 |
|
|
2023
Q1 | $79K | Buy |
1,135
+668
| +143% | +$46.5K | 0.02% | 228 |
|
|
2022
Q4 | $32K | Buy |
467
+190
| +69% | +$13K | 0.01% | 280 |
|
|
2022
Q3 | $15K | Sell |
277
-236
| -46% | -$12.8K | ﹤0.01% | 400 |
|
|
2022
Q2 | $34K | Buy |
513
+91
| +22% | +$6.03K | 0.01% | 272 |
|
|
2022
Q1 | $28K | Buy |
422
+146
| +53% | +$9.69K | 0.01% | 291 |
|
|
2021
Q4 | $16K | Sell |
276
-34
| -11% | -$1.97K | ﹤0.01% | 374 |
|
|
2021
Q3 | $19K | Buy |
310
+83
| +37% | +$5.09K | ﹤0.01% | 335 |
|
|
2021
Q2 | $14K | Buy |
227
+25
| +12% | +$1.54K | ﹤0.01% | 327 |
|
|
2021
Q1 | $10K | Buy |
202
+51
| +34% | +$2.53K | ﹤0.01% | 367 |
|
|
2020
Q4 | $8K | Hold |
151
| – | – | ﹤0.01% | 390 |
|
|
2020
Q3 | $8K | Hold |
151
| – | – | ﹤0.01% | 336 |
|
|
2020
Q2 | $8K | Buy |
+151
| New | +$8K | ﹤0.01% | 329 |
|